Rede Wealth’s Pfizer PFE Stock Holding History

Rede Wealth’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,224	Closed	-$221K	–	99
2022 Q2	$221K	Sell	4,224 -61	-1%	-$3.11K	0.13%	91
2022 Q1	$222K	Sell	4,285 -390	-8%	-$20.2K	0.1%	102
2021 Q4	$276K	Sell	4,675 -50	-1%	-$2.48K	0.14%	89
2021 Q3	$203K	Buy	+4,725	New	+$209K	0.11%	106

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Rede Wealth's PFE Position: Q3 2022 in Review

Rede Wealth sold out of Pfizer (PFE) in Q3 2022, closing a stake of 4,224 shares — an estimated $221K sold.

Rede Wealth first reported a position in PFE in Q3 2021 and held it in 4 quarters. The position peaked at $276K in Q4 2021. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

Rede Wealth reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
Rede Wealth sold 4,224 Pfizer shares in Q3 2022, an estimated $221K.
Rede Wealth first reported a position in Pfizer in Q3 2021 and held it in 4 quarters.
Rede Wealth's Pfizer position peaked at $276K in Q4 2021.
3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on Rede Wealth's 13F filing for Q3 2022, filed 17 Oct 2022.